Compare IPWR & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPWR | XTNT |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | 17 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.4M | 61.7M |
| IPO Year | 2013 | 2009 |
| Metric | IPWR | XTNT |
|---|---|---|
| Price | $3.98 | $0.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $10.75 | $1.00 |
| AVG Volume (30 Days) | ★ 184.8K | 86.3K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.00 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $53,337,000.00 |
| Revenue This Year | $2,603.56 | N/A |
| Revenue Next Year | $1,800.00 | $9.30 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.62 | $0.39 |
| 52 Week High | $9.30 | $0.95 |
| Indicator | IPWR | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 33.12 | 44.03 |
| Support Level | $2.80 | $0.40 |
| Resistance Level | $4.44 | $0.44 |
| Average True Range (ATR) | 0.32 | 0.03 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 8.89 | 31.94 |
Ideal Power Inc is engaged in the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.